BD Physioject™ Disposable Autoinjector 1mL

Easy-to-use, patient-centric design to support complete injection1 of biologics for chronic disease treatment

physioject disposable autoinjector banner 201771882
Loading

Overview

The BD Physioject™ Disposable Autoinjector 1 mL is a commercially proven, easy-to-use, button-activated, disposable autoinjector for the treatment of chronic diseases.2,6,7

The BD Physioject™ Disposable Autoinjector 1 mL combined with BD Hypak™ for Biotech Glass Prefillable Syringes supports dose accuracy and enables the delivery of a complete injection**

Commercially proven through over a decade of market use, the BD Physioject™ Disposable Autoinjector 1 mL is customizable to support your brand strategy.

The BD Physioject™ Disposable Autoinjector 1 mL is designed to ensure controlled needle length exposure to enable injection depth* and offers an integrated sharps injury protection feature.1,2,3,6

Ease of Use award

This product has received the Ease of UseSM Commendation by the Arthritis Foundation®. Products with this commendation are tested and proven to make daily tasks easier.

Learn more

 

physioject autoinjector RC PS SI 06152022 0001
  • physioject autoinjector RC PS SI 06152022 0001
  • physioject autoinjector RC PS SI 06142022 0002
  • physioject autoinjector RC PS SI 06142022 0003
  • physioject autoinjector RC PS SI 06152022 0001
Features and Benefits

Audible and visual feedback indicators

Feedback is provided with an audible click at start, while the 360° view allows visibility to the drug as injection progresses.1

Automatic safety features

Feedback is provided with an audible click at start, while the 360° view allows visibility to the drug as injection progresses.1

Reliable integration

Robust integration with BD Hypak™ for Biotech 1 mIL Glass Prefillable Syringes in 29G Thin Wall and 27G Special-Thin Wall needle configurations.1

Enhances the patient injection experience

The BD Physioject™ Disposable Autoinjector 1 mL is designed to have consistent injection activation, complete injection and ensure controlled injection depth1,3*

Ease of use

Certified by the Arthritis Foundation® as an Ease of Use™ Product in 2015.4

Supports patient safety

The BD Physioject™ Disposable Autoinjector 1 mL is designed with an integrated passive sharps injury protection feature.1,2

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

Notes

* Needle length exposure 8mm +/- 2mm and 6mm +/- 2mm with BD Hypak for Biotech

** Dose accuracy bench tests were done for different conditions (such as cool, standard and warm atmosphere) on 540 samples. Moreover, the stopper used was at the end of the barrel 100% of the time, which confirms that the dose was fully delivered.

† When combined with the BD Hypak™ for Biotech Glass Prefillable Syringes

References

  1. BD Physioject™ design verification report [internal report]. Pont-de-Claix, Fr: Becton, Dickinson and Company; 2018
  2. Physioject™ design input specification [internal report]. Pont-de-Claix, FR: Becton, Dickinson and company; 2014
  3. BD Physioject™ needle penetration depth [internal report]. Pont-de-Claix, FR: Becton, Dickinson and Company; 2010
  4. Arthritis foundation®, https://www.arthritis.org/living-with-arthritis/tools-resources/ease-ofuse/ health-and-wellness/bd-physioject-disposable-autoinjector.php
  5. BD Quality System complaint data (2012-2018), Physioject complaint extract for reported user complaints related to system integration
  6. Berteau, Cecile, et al. (2010), “Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.” Patient Preference and Adherence, Vol. 4, p. 379-388.
  7. Schwarzenbach, Florence, et al. “Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis.” Patient Preference and Adherence, Published in 2014 Vol. 8, p. 199–209
  8. Evaluation of the convenience of use and functionality of BD Physioject™ via simulated injections performed by patients with destructive inflammatory rheumatism [internal study]. Le Pont-de-Claix, FR; Becton, Dickinson and Company; 2011.
  9. BD Physioject™ Disposable Autoinjector 1 mL Human Factor Engineering and User Experience report [internal report]. Le Pont-de-Claix, FR; Becton, Dickinson and Company; 2013.
  10. BD WW Demand Database, WW Sales 2012-2018 for APAC, EU, US, LA.

Expertise

Time-tested system integration

>99.999% system reliability demonstrated for the BD Physioject™ Disposable Autoinjector 1 mL

Commercially proven

BD Physioject™ Disposable Autoinjector 1 mL is a commercially proven, reliable solution supported with rigorous clinical and human factors data1,6,7,8,9

A heritage of excellence

BD Physioject™ Disposable Autoinjector 1 mL builds on the knowledge, data and experience gained from over 10 years of on-market experience and over 118 million units sold.10

Ease of Use award

Ease of Use award

This product has received the Ease of UseSM Commendation by the Arthritis Foundation®. Products with this commendation are tested and proven to make daily tasks easier.

Learn more

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:

Notes

† When combined with the BD Hypak™ for Biotech Glass Prefillable Syringes

References

1. BD Physioject™ design verification report [internal report]. Pont-de-Claix, Fr: Becton, Dickinson and Company; 2018

6. Berteau, Cecile, et al. (2010), “Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers.” Patient Preference and Adherence, Vol. 4, p. 379-388.

7. Schwarzenbach, Florence, et al. “Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis.” Patient Preference and Adherence, Published in 2014 Vol. 8, p. 199–209

8. Evaluation of the convenience of use and functionality of BD Physioject™ via simulated injections performed by patients with destructive inflammatory rheumatism [internal study]. Le Pont-de-Claix, FR; Becton, Dickinson and Company; 2011.

9. BD Physioject™ Disposable Autoinjector 1 mL Human Factor Engineering and User Experience report [internal report]. Le Pont-de-Claix, FR; Becton, Dickinson and Company; 2013.

10. BD WW Demand Database, WW Sales 2012-2018 for APAC, EU, US, LA.

Availability and Support

BD Physioject™ Disposable Autoinjector 1 mL availability and support

  • Product available for clinical and commercial use
  • Available through BD PartnerPath™ Program, enabling speed to market
  • Partners are supported with full system performance data packages.

Ease of Use award

This product has received the Ease of UseSM Commendation by the Arthritis Foundation®. Products with this commendation are tested and proven to make daily tasks easier.

Learn more

 

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Reference
  1. BD Physioject™ design verification report [internal report]. Pont-de-Claix, Fr: Becton, Dickinson and Company; 2018

Related Families

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Reference
  1. BD Physioject™ design verification report [internal report]. Pont-de-Claix, Fr: Becton, Dickinson and Company; 2018
Resources

Let’s have a conversation.

Fill out our form to have one of our experts contact you.

Contact us
For sales inquiries, technical support and customer support complete the following form:
Reference
  1. BD Physioject™ design verification report [internal report]. Pont-de-Claix, Fr: Becton, Dickinson and Company; 2018
Chat with us
Our live chat is available between the hours of 8.30am - 5.00pm EST, Monday - Friday
×